Psychological stress is known to worsen the gut inflammation caused by certain bowel diseases. Now scientists have found out why. New research¹ outlines a sweeping narrative that begins with chemical cues produced in the brain and ends with immune cells in the gut — a sequence that spells trouble for people with these conditions.

The work, published today in Cell, helps to explain how chronic stress can trigger physical distress. And it implies that managing stress levels might have a profound influence over the effectiveness of treatments for inflammatory bowel disease (IBD). That idea runs contrary to conventional medical treatment, which has “completely neglected the psychological state of a patient as a major driver of [the] response to treatment”, says study co-author Christoph Thaiss, a microbiologist at the University of Pennsylvania in Philadelphia.

The path from brain to gut

Abdominal pain, diarrhoea and fatigue are just a few of the symptoms that people with IBD experience. The two main types of IBD, ulcerative colitis and Crohn’s disease, are mild in some people but, in others, can be debilitating or even life-threatening.

Stressful events, such as losing one’s job or breaking up with a partner, often precede IBD flare-ups. Thaiss and his colleagues have now traced that linkage. After a surge of stress, the brain sends signals to the adrenal glands, which release chemicals called glucocorticoids to the rest of the body.

Anxiety can be created by the body, mouse heart study suggests

Initially, the researchers considered the idea that glucocorticoids act directly on immune cells, which respond by releasing molecules that cause inflammation. “But it turns out that there is a sort of layer in between,” Thaiss says. Working in mice, they found that glucocorticoids act instead on neurons in the gut and on cells called glia that connect gut neurons to one another.

Co-opted immune cells

After being switched on by glucocorticoids, some glial cells release molecules that trigger immune cells. In turn, those immune cells release molecules that would normally be used to fight off pathogens, but in this case end up causing painful bowel inflammation.

At the same time, glucocorticoids block immature gut neurons from developing fully, the researchers found. As a consequence, these neurons produce only low levels of signalling molecules that cause gut muscles to contract. This means food moves slowly through the digestive system, which adds to the discomfort of IBD.

The researchers were surprised to learn that glucocorticoids cause gut inflammation, because these compounds are sometimes used to treat IBD. This apparent paradox might be explained by the short time frame on which such treatments are used. Although quick bursts of glucocorticoids seem to be anti-inflammatory, when stress becomes chronic, “the system completely shifts” and glucocorticoids take on a pro-inflammatory role, Thaiss says. It’s a “plausible explanation”, says gastroenterologist and immunologist John Chang at the University of California, San Diego.

Stress management for symptom relief

The brain’s ability to drive inflammation in far-flung organs “seems to be much stronger” than was thought before, Thaiss says. This suggests that IBD drugs, in combination with stress-management techniques, could be more effective than the drugs alone. Molecules in the signalling pathway that runs from the brain to the gut could also become targets for new pharmacological treatments — “an exciting possibility”, Chang says.

The implications of the work could reach beyond IBD. Stress is also thought to heighten inflammatory diseases of the skin and lungs, possibly through similar signalling pathways.

Moving forwards, Thaiss is excited to explore whether brain states other than stress influence a person’s overall health. “There’s definitely a huge amount we still need to learn about the brain and how the brain controls seemingly unrelated aspects of physiology and disease.”